Yuhua Jia
Biographic Data
| ID | 7269384 |
|---|---|
| NAME | Yuhua Jia |
| GIVEN NAMES | Yuhua |
| FAMILY NAME | Jia |
| SIGNATURE | JIA Y |
| AFFILIATIONS | Southern Medical University |
| ORCID | 0000-0001-6508-4418 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Dingxin recipe III ameliorates endothelial cell senescence in atherosclerosis by activating the Foxo3a/Pink1/Parkin axis
Our findings for the first time demonstrated that DXRIII effectively alleviates endothelial senescence and HFD-induced AS, possibly by activating FOXO3a and subsequently enhancing PINK1/Parkin-mediated mitophagy
Dingxin recipe III ameliorates hyperlipidemia injury in SD rats by improving the gut barrier, particularly the SCFAs/GPR43 pathway
DXR III protects against hyperlipidemia by improving the gut barrier, particularly the SCFAs/GPR43 pathway
Geniposide ameliorates atherosclerosis by regulating macrophage polarization via perivascular adipocyte-derived CXCL14
In summary, our findings suggest that geniposide protects ApoE -/- mice against WD-induced atherosclerosis by inducing M2 polarization of plaque macrophages via enhanced expression of CXCL14 in PVAT. These data provide novel insights into PVAT paracrine function in atherosclerosis and reaffirm geniposide as a therapeutic drug candidate for atherosclerosis treatment
Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD
DXR IV exhibits potential anti-atherosclerosis effect, which is closely related to lipid metabolism and the gut microbiota. This study may provide novel insights into the mechanism of DXR IV on atherosclerosis and a basis for promising clinical usage
No prominent works on this page.
Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD
DXR IV exhibits potential anti-atherosclerosis effect, which is closely related to lipid metabolism and the gut microbiota. This study may provide novel insights into the mechanism of DXR IV on atherosclerosis and a basis for promising clinical usage
Dingxin recipe III ameliorates hyperlipidemia injury in SD rats by improving the gut barrier, particularly the SCFAs/GPR43 pathway
DXR III protects against hyperlipidemia by improving the gut barrier, particularly the SCFAs/GPR43 pathway
Geniposide ameliorates atherosclerosis by regulating macrophage polarization via perivascular adipocyte-derived CXCL14
In summary, our findings suggest that geniposide protects ApoE -/- mice against WD-induced atherosclerosis by inducing M2 polarization of plaque macrophages via enhanced expression of CXCL14 in PVAT. These data provide novel insights into PVAT paracrine function in atherosclerosis and reaffirm geniposide as a therapeutic drug candidate for atherosclerosis treatment
Dingxin recipe III ameliorates endothelial cell senescence in atherosclerosis by activating the Foxo3a/Pink1/Parkin axis
Our findings for the first time demonstrated that DXRIII effectively alleviates endothelial senescence and HFD-induced AS, possibly by activating FOXO3a and subsequently enhancing PINK1/Parkin-mediated mitophagy
Medicine (4 works) · Pharmacology (4 works) · Chemistry (3 works) · Endocrinology (3 works) · Adipose tissue (2 works) · Atherosclerosis and Cardiovascular Diseases (2 works) · Biochemistry (2 works) · Ginseng Biological Effects and Applications (2 works) · Internal Medicine (2 works) · Traditional medicine (2 works)